{"id":"W4389836815","doi":"10.1007/s00520-023-08176-6","title":"Efbemalenograstim alfa, an Fc fusion protein, long-acting granulocyte-colony stimulating factor for reducing the risk of febrile neutropenia following chemotherapy: results of a phase III trial","year":2023,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Custom Security Industries (Canada)","funders":"","keywords":"Medicine; Febrile neutropenia; Placebo; Docetaxel; Neutropenia; Internal medicine; Chemotherapy; Clinical endpoint; Adverse effect; Incidence (geometry); Breast cancer; Surgery; Absolute neutrophil count; Randomized controlled trial; Gastroenterology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006353353,0.0002592768,0.0007272703,0.0002324903,0.0002440535,0.00002059807,0.0001543761,0.0001205774,0.0001430731],"category_scores_gemma":[0.0004539719,0.0001988772,0.0003808368,0.0008424897,0.0001008822,0.0002131092,0.00005640826,0.0003418307,0.000001352701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003019285,"about_ca_system_score_gemma":0.000562637,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003557853,"about_ca_topic_score_gemma":0.002066676,"domain_scores_codex":[0.997539,0.0001525518,0.0009587459,0.0005227193,0.0003787491,0.0004481819],"domain_scores_gemma":[0.9979583,0.0003209222,0.000748432,0.0004262116,0.0004389242,0.00010719],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.2799398,0.0008970771,0.07063657,0.001318278,0.0008109058,0.00008605394,0.04638028,0.004681746,0.3251095,0.00000703402,0.0006831835,0.2694497],"study_design_scores_gemma":[0.4074304,0.02316434,0.07616372,0.00456548,0.001425409,0.00001006515,0.01915478,0.003894354,0.4594288,0.00004722556,0.003681626,0.001033783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924994,0.0002501377,0.0001671416,0.00020227,0.0006975314,0.005070502,0.0008495502,0.00007196008,0.0001915398],"genre_scores_gemma":[0.9978155,0.00009770835,0.0001662834,0.0000443297,0.0004358621,0.001046438,0.0001565672,0.00006578384,0.0001714675],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2684159,"threshold_uncertainty_score":0.8109975,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04650877393839486,"score_gpt":0.3896005932456712,"score_spread":0.3430918193072763,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}